No abstract
To The Editor: We report an unusual case of metachronous T-cell post-transplant lymphoproliferative disease (PTLD) with clinicopathologic manifestations resembling chronic active Epstein-Barr virus (CAEBV) infection of T/NK subtype and hemophagocytic lymphohistiocytosis (HLH), more than 4 years following the occurrence of B-cell PTLD.A 15 year-old Chinese girl, in end-stage renal failure since 13 years of age from chronic glomerulonephritis, received a cadaveric donor Epstein-Barr virus (EBV)-unknown to recipient-seronegative renal transplant. She received EBV prophylaxis with oral valganciclovir.Five months post-transplant, she developed exudative tonsillitis and underwent tonsillectomy. Histology of the tonsils revealed a diffuse, destructive, and polymorphous lymphoid infiltrate composed of lymphoid cells showing a full range of B-cell maturation. The lymphoid cells were positive for CD20, CD79A, and showed kappa light chain restriction (Supporting Information Fig. 1). In situ hybridization for Epstein-Barr virusencoded small ribonucleic acid (EBER) was positive in B-cells but not T-cells. Features were consistent with EBV-positive PTLD, polymorphic type. Positron emission tomography-computed tomography (PET-CT) scan showed an intensely fluorodeoxyglucose (FDG)-avid soft tissue mass lesion in the nasopharynx and posterior nasal cavity associated with retropharyngeal and cervical adenopathy. Plasma EBV DNA by polymerase chain reaction (PCR) was 134 copies per lg DNA (reference <100 copies per lg DNA). Throat swab EBV DNA was 1,225 copies per lg DNA. She was treated with intravenous rituximab and immunoglobulin with continued antiviral therapy. Immunosuppression was reduced with tacrolimus weaned to minimal levels. Repeat PET-CT scan following tonsillectomy showed resolution of the FDG-avid lesions.In the ensuing period from 2 to 3 years post-transplant, the patient experienced recurrent episodes of pancytopenia which required treatment with granulocyte-colony stimulating factor. Throughout this period, her EBV viral load remained high (1,500-2,500 copies per lg DNA) while surveillance PET-CT scans were negative for metabolically active lesions. The cause of the pancytopenia was attributed to persistent EBV viremia with marrow suppression.Four years and 6 months post-transplant, the patient was treated for acute cellular rejection with intravenous pulse methylprednisolone. A month later, she developed high fevers, epistaxis, and spontaneous bruising. Physical examination revealed hepatosplenomegaly, cervical lymphadenopathy, and lower limb ecchymoses. Investigations showed pancytopenia with haemoglobin 7.1 g/dL, total white cell count 2.72 3 10
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.